Skip to content

SankoreAfrican research intelligence

Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Maxwell O. Akanbi · Sankore

University of Jos

Maxwell O. Akanbi

ORCID, self-asserted

ORCID 0000-0001-6022-2359

This profile carries an ORCID the researcher published on their own record — the strongest evidence available short of a human confirming it.

Publications

3

Citations

17

h-index

3

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

1

Works published 2022 onward have been swept for this country. Figures are complete within that window, to the extent the open indexes are.

Publications

3 works in the graph, newest first.

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study
2023BMC CancerJournalOpen accessFirst authorCorresponding3 citations10.1186/s12885-023-11402-3
Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–2017
2022Infectious Agents and CancerJournalOpen accessFirst authorCorresponding4 citations10.1186/s13027-022-00424-4
The role of immunotherapy plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-small cell lung cancer: an updated systematic review and meta-analysis of randomized controlled trials
2022Expert Review of Anticancer TherapyJournal10 citations10.1080/14737140.2022.2116005